These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29963460)

  • 1. Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy.
    Mf Akbar S; Al-Mahtab M; I Khan S
    Euroasian J Hepatogastroenterol; 2018; 8(1):42-46. PubMed ID: 29963460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost Assessment of Hepatitis B Virus-related Hepatitis in Bangladesh.
    Mahtab MA; Chaudhury M; Uddin MH; Noor-E Alam SM; Rahim MA; Alam MA; Moben AL; Khondaker FA; Choudhury MF; Sarkar MJ; Poddar PK; Foez SA; Akbar SM
    Euroasian J Hepatogastroenterol; 2016; 6(2):163-166. PubMed ID: 29201750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering immune therapy against hepatitis B virus.
    Akbar F; Yoshida O; Abe M; Hiasa Y; Onji M
    Hepatol Res; 2007 Oct; 37 Suppl 3():S351-6. PubMed ID: 17931186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for Chronic Hepatitis B using HBsAg-based Vaccine Formulations: From Preventive Commercial Vaccines to Therapeutic Approach Julio Cesar Aguilar.
    Cesar Aguilar J; Y L
    Euroasian J Hepatogastroenterol; 2014; 4(2):92-97. PubMed ID: 29699355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection.
    Akbar SM; Horiike N; Onji M
    World J Gastroenterol; 2006 May; 12(18):2876-83. PubMed ID: 16718812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Hepatitis B Virus and Hepatitis C Virus in a Tea Garden of Bangladesh.
    Al Mahtab M; Akhter S; U Mollick K; H Uddin M; I Khan S; Mf Akbar S
    Euroasian J Hepatogastroenterol; 2017; 7(1):107-110. PubMed ID: 29201788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine therapy for hepatitis B virus carrier.
    Akbar SM; Furukawa S; Horiike N; Onji M
    Curr Drug Targets Infect Disord; 2004 Jun; 4(2):93-101. PubMed ID: 15180457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis B virus infection in Asian countries.
    Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.
    Rapti I; Hadziyannis S
    World J Hepatol; 2015 May; 7(8):1064-73. PubMed ID: 26052395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
    Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
    J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection.
    Akbar SMF; Al Mahtab M; Yoshida O; Aguilar J; Gerardo GN; Hiasa Y
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
    van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
    J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine.
    Stasi C; Silvestri C; Voller F; Cipriani F
    J Infect Public Health; 2016; 9(4):389-95. PubMed ID: 26148849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Hepatitis B Viral Deoxyribonucleic Acid Load and Hepatocellular Carcinoma.
    M Hussain M; Al Mahtab M; Islam S; Ahmed N; Rahman S; Khan M
    Euroasian J Hepatogastroenterol; 2017; 7(1):111-112. PubMed ID: 29201789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions.
    Inuzuka T; Takahashi K; Chiba T; Marusawa H
    Pathogens; 2014 Apr; 3(2):377-89. PubMed ID: 25437805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protection.
    Morikawa K; Shimazaki T; Takeda R; Izumi T; Umumura M; Sakamoto N
    Ann Transl Med; 2016 Sep; 4(18):337. PubMed ID: 27761441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.